Abstract
There is strong circumstantial evidence that multiple sclerosis (MS) is an autoimmune disease. Nonspecific in immunosuppressive therapy has not been successful in altering the natural course of the illness. Bone marrow transplantation has heretofore been a radical therapy used in patients with life-threatening malignancies but has potential as a treatment for human autoimmunity. In MS there have been no controlled studies. We report here four patients with MS undergoing bone marrow transplantation with 6–48 months of follow-up. In three this was carried out for co-existing malignancy in one as an experimental treatment for MS using the patient's unaffected identical twin as a donor. The limited outcome that can be evaluated in these patients supports further experimentation into this treatment modality in MS patients with poor prognostic indications.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Additional information
Received: 12 January 2000/Received in revised form: 15 March 2000/Accepted: 23 March 2000
Rights and permissions
About this article
Cite this article
Mandalfino, P., Rice, G., Smith, A. et al. Bone marrow transplantation in multiple sclerosis. J Neurol 247, 691–695 (2000). https://doi.org/10.1007/s004150070112
Issue Date:
DOI: https://doi.org/10.1007/s004150070112